Small Molecules
27 March 2015
Conatus Announces Successful Top-Line Results From NAFLD/NASH Clinical Trial of Emricasan27 March 2015
pSivida Corp. Completes Targeted Enrollment of Phase III Trial of Medidur™ for Posterior Uveitis27 March 2015
Kineta’s Novel Antiviral Compounds Inhibit Broad Array of Emerging and Current Viruses Including Ebola21 March 2015
GSK announces start of phase III programme to evaluate retosiban for spontaneous preterm labour20 March 2015
Pfizer Announces Oral Tofacitinib Meets Primary Endpoints In Pivotal Phase 3 Psoriasis Trials20 March 2015
GSK and Theravance Announce Outcome of US FDA Advisory Committee on BREO(R) ELLIPTA(R) in Asthma19 March 2015
ProMetic Life Sciences successfully completes its PBI-4050 phase Ib in patients with chronic kidney disease (“CKD”)19 March 2015
Kineta’s ShK-186 Shows Encouraging Early Results as Potential Therapy for Autoimmune Eye Diseases19 March 2015
Creabilis’ CT327 Phase 2b Data Published in Acta Dermato-Venereologica, Strengthens Scientific Advisory Board18 March 2015
AstraZeneca announces positive Phase III top-line results for PT003 from PINNACLE 1 and PINNACLE 2 studies in COPDNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports